These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8516947)

  • 1. Individual and species differences in the in vitro sensitivity to brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Hill D; Frankland M; Hough K; Mills L; Nicholson B; Chapman F; Jaffee B
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):61-4. PubMed ID: 8516947
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged xenograft survival following combination therapy with brequinar sodium and cyclosporine.
    Cosenza CA; Tuso PJ; Chapman FA; Middleton YD; Cramer DV; Wu GD; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):59-60. PubMed ID: 8516946
    [No Abstract]   [Full Text] [Related]  

  • 5. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 7. Brequinar sodium: inhibition of dihydroorotic acid dehydrogenase, depletion of pyrimidine pools, and consequent inhibition of immune functions in vitro.
    Simon P; Townsend RM; Harris RR; Jones EA; Jaffee BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):77-80. PubMed ID: 8390742
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of brequinar sodium on in vivo antibody production.
    Yasunaga C; Cramer DV; Cosenza CA; Tuso PJ; Chapman FA; Barnett M; Wu GD; Putnam BA; Makowka L
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):40-4. PubMed ID: 8516942
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
    Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival.
    Woo J; Valdivia LA; Pan F; Celli S; Fung JJ; Thomson AW
    Ann N Y Acad Sci; 1993 Nov; 696():227-34. PubMed ID: 8109830
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
    Catena M; Woo J; Valdivia LA; Celli S; Pan F; Fung JJ; Starzl TE; Thompson AW
    Transplant Proc; 1994 Jun; 26(3):1288-9. PubMed ID: 8029911
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of brequinar sodium for preventing cardiac allograft rejection in primates.
    Makowka L; Tixier D; Chaux A; Hill D; O'Neill P; Eiras-Hreha G; Wu GD; Cunneen S; Cajulis E; Zajac I
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):48-53. PubMed ID: 8516944
    [No Abstract]   [Full Text] [Related]  

  • 15. Leflunomide and cyclosporine immunomodulation in intestinal xenotransplantation.
    Foster PF; Kociss K; Shen J; Sankary HN; Xiao F; Williams JW
    Transplant Proc; 1996 Oct; 28(5):2527-8. PubMed ID: 8907935
    [No Abstract]   [Full Text] [Related]  

  • 16. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS; Shen J; Xiao F; Blinder L; Foster P; Sankary H; Williams JW
    Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
    [No Abstract]   [Full Text] [Related]  

  • 17. Xenoislet rejection following pig-to-rat, pig-to-primate, and pig-to-man transplantation.
    Groth CG; Korsgren O; Wennberg L; Tibell A; Zhu S; Sundberg B; Söderlund J; Biberfeld P; Satake M; Möller E; Wallgren AC; Karlsson-Parra A
    Transplant Proc; 1996 Apr; 28(2):538-9. PubMed ID: 8623254
    [No Abstract]   [Full Text] [Related]  

  • 18. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
    Little DM; Stoltenberg RL; Hullett DA; Sollinger HW
    Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445
    [No Abstract]   [Full Text] [Related]  

  • 20. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
    Dunn JF; Hatch J; Precht A; Hart M; Li S
    Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.